Author

R. Tandon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4 Biochemistry· 3 Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 8 Organism:human· 6 Research Focus:host-pathogen & immune response· 5 Assay:proteomics· 4 Organism:mouse· 3 Research Focus:drug response / drug discovery· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

D. Mitra· 3 shared K. K. Mohanty· 2 shared S. A. Patil· 2 shared S. Jena· 2 shared S. K. Barik· 2 shared S. P. Tripathy· 2 shared T. P. Singh· 2 shared V. Tiwari· 2 shared

Activity by Year

2018-2023 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

D. Mitra

Mutual co-authors in cluster

Author profile →

9 papers

Recent·Most cited

Distinct composition of plasma virome in HIV-infected subjects on antiretroviral therapy compared to controls

T. Bhagchandani, M. M. U. Haque, M. Z. Malik, A. K. Ray, U. K. S, A. Rai, A. Verma, K. K. Sawlani, R. Chaturvedi, H. D, R. Tandon

This study compares the plasma virome of HIV-infected patients on antiretroviral therapy with controls, finding significant differences in viral composition.

bioRxiv · Jul 21, 2023 · PreprintMicrobiology

Targeting MAPAKAP2(MK2) to combat inflammation by avoiding the differential regulation of anti-inflammatory genes by p38 MAPK inhibitors

R. K. Singh, R. Sodhi, S. Sharma, S. G. Dastidar, R. Tandon

The paper evaluates MK2 inhibitors as a safer alternative to p38 MAPK inhibitors for anti-inflammatory therapy by comparing their toxicity and efficacy in cell-based assays.

bioRxiv · Jul 17, 2022 · PreprintPharmacology & Toxicology

Developing selective FPR2 agonists can be a potential approach to treat moderate to severe asthma.

S. A. Visaga, H. Kalonia, V. Verma, S. Sinha, S. K. Singh, S. Upadhyay, S. Sahdev, A. Pansari, R. Kumar, M. Bandgar, N. Karanjule, R. K. Shirumalla, K. Morishita, R. Tandon

The paper develops selective FPR2 agonists and shows they reduce non-resolving inflammation in asthma models.

bioRxiv · Sep 16, 2021 · PreprintPharmacology & Toxicology

The degree of polymerization and sulfation patterns in heparan sulfate are critical determinants of cytomegalovirus entry into host cells

M. Hasan, D. Mitra, R. Parmar, L. A. Fassero, Q. Liang, H. Qiu, V. Tiwari, J. Sharp, L. Wang, R. Tandon

bioRxiv · Mar 24, 2021 · PreprintMicrobiology

Identification and characterization of novel plasma proteins in drug resistant HIV/AIDS patients by SWATH-MS

S. K. Barik, S. P. Tripathy, D. K. Bisht, P. Singh, R. Chakraborty, M. K. Chadar, S. A. Patil, T. P. Singh, R. Tandon, S. Jena, K. K. Mohanty

This study identifies and characterizes novel plasma proteins differentially expressed in drug-resistant HIV/AIDS patients using SWATH-MS.

bioRxiv · Mar 4, 2021 · PreprintBiochemistry

Comparative evaluation of plasma protein purification and 2-D gel electrophoresis protocols for analysis of HIV-1 infected human plasma proteins

S. K. Barik, D. K. Barik, K. K. Mohanty, D. Bisht, S. A. Patil, R. Singh, D. K. Sharma, S. P. Tripathy, R. Tandon, T. P. Singh, S. Jena

The paper evaluates plasma protein purification protocols for HIV-1 infected human plasma, finding that the Aurum serum mini kit provides better resolution of low-abundance proteins in 2-D gel electrophoresis.

bioRxiv · Mar 3, 2021 · PreprintBiochemistry

Preferential recognition and antagonism of SARS-CoV-2 spike glycoprotein binding to 3-O-sulfated heparan sulfate

V. Tiwari, R. Tandon, N. V. Sankaranarayanan, J. C. Beer, E. K. Kohlmeir, M. Swanson-Mungerson, U. R. Desai

This study shows 3-O-sulfated heparan sulfate enhances SARS-CoV-2 spike protein-mediated cell fusion, which can be blocked by a synthetic small molecule.

bioRxiv · Oct 8, 2020 · PreprintBiochemistry

Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives

R. Tandon, J. S. Sharp, F. Zhang, V. H. Pomin, N. M. Ashpole, D. Mitra, W. Jin, H. Liu, P. Sharma, R. J. Linhardt

This study evaluates the antiviral activity of heparin and enoxaparin derivatives against SARS-CoV-2 by testing their ability to neutralize pseudotyped virus particles.

bioRxiv · Jun 8, 2020Microbiology

Dynamin is required for efficient cytomegalovirus maturation and envelopment

M. H. Hasan, L. Davis, R. K. Bollavarapu, D. Mitra, R. C. Parmar, R. Tandon

This study shows dynamin is required for efficient cytomegalovirus maturation and envelopment, but not for early infection stages.

bioRxiv · Aug 21, 2018Microbiology